No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
CHMP Recommends Label Update for Roche’s Pertuzumab/Trastuzumab Combo; Roche Unconcerned About Pertuzumab Biosimilar Threat
On 30 April 2025, Roche announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending an update to the European Union (EU) label for Phesgo®…